Thus, as NDC-mediated inhibition is beneficial in cancer cells but may suppress anticancer response by the innate immune system, further studies using in vivo models may elucidate possible benefits on the interaction between NDC from plant-source foods and CLR in decreasing CRC risk. The gene discussed is DCLK3; the disease is colorectal carcinoma.